Viewing Study NCT06261957

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-01-06 @ 3:51 AM
Study NCT ID: NCT06261957
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-03
First Post: 2024-02-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Asthma View
None Salbutamol View
None MDI View
None HFA-152a View
None HFA-134a View